Stock comparison
Merck & Co., Inc. is 66.7x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($371.29 B vs $5.56 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 66.7x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($371.29 B vs $5.56 B).
Market value leader
MRK
Merck & Co., Inc. is 66.7x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($371.29 B vs $5.56 B).
Revenue leader
MRK
AMRX: $3.02B vs MRK: $65.01B.
Profit leader
MRK
AMRX: $72.06M vs MRK: $18.25B.
Margin leader
MRK
AMRX: 2.4% vs MRK: 28.1% net margin.
| Metric | AMRX | MRK |
|---|---|---|
| Market cap | $5.56 B | $371.29 B |
| US-listed rank | #1339 | #34 |
| Revenue (latest FY) | $3.02B | $65.01B |
| Net income (latest FY) | $72.06M | $18.25B |
| Net margin | 2.4% | 28.1% |
| P/E (trailing FY) | 77.2x | 20.3x |
| SEC filings | 662 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 66.7x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($371.29 B vs $5.56 B).
In their latest fiscal years, Amneal Pharmaceuticals, Inc. reported $3.02B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Amneal Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.